News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Carna Biosciences, CrystalGenomics And Rigel Pharmaceuticals, Inc. (RIGL) Sign Service Agreement For X-Ray Crystal Structure Analysis


10/19/2005 5:09:20 PM

Tokyo (JCNN) - Carna Biosciences of Kobe and Korean pharmaceutical company CrystalGenmomics jointly announced on June 20 that they have signed a service agreement with US pharmaceutical company Rigel Pharmaceuticals. Under the terms of the agreement, Carna Biosciences and CrystalGenomis will jointly provide X-ray crystal structure analysis service to Rigel Pharmaceuticals.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES